(Q43287373)

English

A study of rasburicase for the management of hyperuricemia in pediatric patients with newly diagnosed hematologic malignancies at high risk for tumor lysis syndrome

scientific article published on 22 August 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

A study of rasburicase for the management of hyperuricemia in pediatric patients with newly diagnosed hematologic malignancies at high risk for tumor lysis syndrome (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

author name string

Akira Kikuchi

1

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Hisato Kigasawa

2

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Masahito Tsurusawa

3

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Keisei Kawa

4

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Atsushi Kikuta

5

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Masahiro Tsuchida

6

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Yoshihisa Nagatoshi

7

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Keiko Asami

8

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Keizo Horibe

9

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Atsushi Makimoto

10

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Ichiro Tsukimoto

11

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

publication date

22 August 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

International Journal of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

90

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

492-500

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

https://scigraph.springernature.com/pub.10.1007/s12185-009-0402-6

0 references

Spotlight on rasburicase in anticancer therapy-induced hyperuricemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19701676

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant urate oxidase (Rasburicase) for the treatment of hyperuricemia in pediatric patients with hematologic malignancies: Results of a compassionate prospective multicenter study in Korea.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19701676

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rasburicase: a new approach for preventing and/or treating tumor lysis syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/19701676

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review

1 reference

https://pubmed.ncbi.nlm.nih.gov/19701676

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19701676

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor lysis syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/19701676

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant urate oxidase (rasburicase) in the prevention and treatment of malignancy-associated hyperuricemia in pediatric and adult patients: results of a compassionate-use trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19701676

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19701676

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant urate oxidase (rasburicase) for the prevention and treatment of tumor lysis syndrome in patients with hematologic malignancies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19701676

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/19701676

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Report of two cases of rasburicase-induced methemoglobinemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19701676

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cloning and expression in Escherichia coli of the gene encoding Aspergillus flavus urate oxidase

1 reference

https://pubmed.ncbi.nlm.nih.gov/19701676

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: final results of a multicenter compassionate use trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19701676

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19701676

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Managing malignancy-associated hyperuricemia with rasburicase.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19701676

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer: report of an international compassionate use study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19701676

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal dysfunction and hyperuricemia at presentation and relapse of acute lymphoblastic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19701676

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rasburicase: a potent uricolytic agent

1 reference

https://pubmed.ncbi.nlm.nih.gov/19701676

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19701676

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19701676

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SFCE (Société Française de Lutte contre les Cancers et Leucémies de l'Enfant et de l'Adolescent) recommendations for the management of tumor lysis syndrome (TLS) with rasburicase: an observational survey.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19701676

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention and treatment of hyperuricemia with rasburicase in children with leukemia and non-Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19701676

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute renal failure at onset of therapy for advanced stage Burkitt lymphoma and B cell acute lymphoblastic lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19701676

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clarifying the role of rasburicase in tumor lysis syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/19701676

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rasburicase therapy in acute hyperuricemia and renal dysfunction

1 reference

https://pubmed.ncbi.nlm.nih.gov/19701676

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12185-009-0402-6

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43287373&oldid=1985591861"